Acute worsening of glycemic control in a patient with type 2 diabetes and non-small cell lung cancer after administration of lorlatinib

Autor:	Fujisawa T, Miyasato-Isoda M, Ghoma I, Nakano Y
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty endocrine system diseases business.industry nutritional and metabolic diseases Type 2 diabetes medicine.disease Lorlatinib Text mining Internal medicine medicine Non small cell Lung cancer business Administration (government) Glycemic
DOI:	10.22541/au.163296666.67375597/v1
Popis:	A case with non-small cell lung cancer exhibited extreme hyperglycemia after lorlatinib treatment, whose adverse effects on hyperglycemia is little known. But, the lorlatinib could be continued by intensifying diabetes treatment, indicating the importance of glucose monitoring during lorlatinib administration, and of adequate intensification of treatment for such hyperglycemia.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::53b0386fb5314c56e06efbc5902749d3 https://doi.org/10.22541/au.163296666.67375597/v1 Zobrazit plný text záznamu